Literature DB >> 19835996

Amino acid and structural variability of Yersinia pestis LcrV protein.

Andrey P Anisimov1, Svetlana V Dentovskaya, Evgeniy A Panfertsev, Tat'yana E Svetoch, Pavel Kh Kopylov, Brent W Segelke, Adam Zemla, Maxim V Telepnev, Vladimir L Motin.   

Abstract

The LcrV protein is a multifunctional virulence factor and protective antigen of the plague bacterium and is generally conserved between the epidemic strains of Yersinia pestis. We investigated the diversity in the LcrV sequences among non-epidemic Y. pestis strains which have a limited virulence in selected animal models and for humans. Sequencing of lcrV genes from 19 Y. pestis strains belonging to different phylogenetic groups (subspecies) showed that the LcrV proteins possess four major variable hotspots at positions 18, 72, 273, and 324-326. These major variations, together with other minor substitutions in amino acid sequences, allowed us to classify the LcrV alleles into five sequence types (A-E). We observed that the strains of different Y. pestis "subspecies" can have the same type of LcrV, including that conserved in epidemic strains, and different types of LcrV can exist within the same natural plague focus. Therefore, the phenomenon of "selective virulence" characteristic of the strains of the microtus biovar is unlikely to be the result of polymorphism of the V antigen. The LcrV polymorphisms were structurally analyzed by comparing the modeled structures of LcrV from all available strains. All changes except one occurred either in flexible regions or on the surface of the protein, but local chemical properties (i.e. those of a hydrophobic, hydrophilic, amphipathic, or charged nature) were conserved across all of the strains. Polymorphisms in flexible and surface regions are likely subject to less selective pressure, and have a limited impact on the structure. In contrast, the substitution of tryptophan at position 113 with either glutamic acid or glycine likely has a serious influence on the regional structure of the protein, and these mutations might have an effect on the function of LcrV. The polymorphisms at positions 18, 72 and 273 were accountable for differences in the oligomerization of LcrV. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19835996      PMCID: PMC2818281          DOI: 10.1016/j.meegid.2009.10.003

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  81 in total

1.  A graph-theory algorithm for rapid protein side-chain prediction.

Authors:  Adrian A Canutescu; Andrew A Shelenkov; Roland L Dunbrack
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

2.  Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.

Authors:  Arif Azam Khan; Jaya Prakash Babu; Geetanjali Gupta; D N Rao
Journal:  Vaccine       Date:  2007-12-03       Impact factor: 3.641

3.  Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.

Authors:  Jeanette E Bröms; Matthew S Francis; Ake Forsberg
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

4.  Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis.

Authors:  R William Depaolo; Fangming Tang; Inyoung Kim; Mei Han; Nadine Levin; Nancy Ciletti; Anning Lin; Debra Anderson; Olaf Schneewind; Bana Jabri
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

5.  Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis.

Authors:  Caroline Gébus; Gébus Caroline; Eric Faudry; Faudry Eric; Yu-Sing Tammy Bohn; Sylvie Elsen; Elsen Sylvie; Ina Attree
Journal:  J Biol Chem       Date:  2008-06-26       Impact factor: 5.157

6.  Variability of the protein sequences of lcrV between epidemic and atypical rhamnose-positive strains of Yersinia pestis.

Authors:  Andrey P Anisimov; Evgeniy A Panfertsev; Tat'yana E Svetoch; Svetlana V Dentovskaya
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

7.  Small protective fragments of the Yersinia pestis V antigen.

Authors:  Claire Vernazza; Bry Lingard; Helen C Flick-Smith; Leslie W J Baillie; Jim Hill; Helen S Atkins
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

8.  Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.

Authors:  Andreas Sing; Natalia Tvardovskaia; Dagmar Rost; Carsten J Kirschning; Hermann Wagner; Jürgen Heesemann
Journal:  Int J Med Microbiol       Date:  2003-11       Impact factor: 3.473

9.  Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.

Authors:  Marie-Noëlle Marenne; Laure Journet; Luis Jaime Mota; Guy R Cornelis
Journal:  Microb Pathog       Date:  2003-12       Impact factor: 3.738

10.  Insight into microevolution of Yersinia pestis by clustered regularly interspaced short palindromic repeats.

Authors:  Yujun Cui; Yanjun Li; Olivier Gorgé; Mikhail E Platonov; Yanfeng Yan; Zhaobiao Guo; Christine Pourcel; Svetlana V Dentovskaya; Sergey V Balakhonov; Xiaoyi Wang; Yajun Song; Andrey P Anisimov; Gilles Vergnaud; Ruifu Yang
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more
  22 in total

1.  Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Authors:  Juliette K Tinker; Chadwick T Davis; Britni M Arlian
Journal:  Protein Expr Purif       Date:  2010-05-11       Impact factor: 1.650

Review 2.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

3.  High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.

Authors:  Duraisamy Ponnusamy; Eric C Fitts; Jian Sha; Tatiana E Erova; Elena V Kozlova; Michelle L Kirtley; Bethany L Tiner; Jourdan A Andersson; Ashok K Chopra
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

4.  LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Authors:  Wei Sun; Shilpa Sanapala; Jeremy C Henderson; Shandiin Sam; Joseph Olinzock; M Stephen Trent; Roy Curtiss
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

5.  Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.

Authors:  Tatiana E Erova; Jason A Rosenzweig; Jian Sha; Giovanni Suarez; Johanna C Sierra; Michelle L Kirtley; Christina J van Lier; Maxim V Telepnev; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

6.  Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial.

Authors:  Kai Chu; Jialei Hu; Fanyue Meng; Jingxin Li; Li Luo; Jianjun Xu; Zhonghang Yuan; Zhiyong Li; Wangeng Chen; Lei Jiao; Yali Chang; Bingxiang Wang; Yuemei Hu
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

7.  A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

Authors:  Jian Sha; Michelle L Kirtley; Curtis Klages; Tatiana E Erova; Maxim Telepnev; Duraisamy Ponnusamy; Eric C Fitts; Wallace B Baze; Satheesh K Sivasubramani; William S Lawrence; Igor Patrikeev; Jennifer E Peel; Jourdan A Andersson; Elena V Kozlova; Bethany L Tiner; Johnny W Peterson; David McWilliams; Snehal Patel; Eric Rothe; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

Review 8.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

9.  Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague.

Authors:  Wei Sun; Joseph Olinzock; Shifeng Wang; Shilpa Sanapala; Roy Curtiss
Journal:  Pathog Dis       Date:  2013-09-10       Impact factor: 3.166

10.  Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.

Authors:  Bethany L Tiner; Jian Sha; Duraisamy Ponnusamy; Wallace B Baze; Eric C Fitts; Vsevolod L Popov; Christina J van Lier; Tatiana E Erova; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2015-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.